Blog / Archives
Sell-Off Resumes as European Debt Crisis Gets Headlines
No Eurobond and Possible Financial Transaction Tax NASDAQ down 0.9% % and S&P down 0.7 % as Bear Returns but Off Session Lows Earlier in Trading The three day stock market rally is on hold for...
Q2 Review of Pure Play Diagnostic Companies:Bargain Hunting in ABAX,GPRO,QGEN
Summary of Q2 Earnings and Valuation Metrics of Selected Pure Play Dx Companies Company Ticker Price RevEst Q1Rev Q2Rev Price Mcap P/S PE PEG 5/18/11 $M Yr. $M 15-Aug $M GenProbe GPRO 80 579 143 136...
Eurozone Crisis Creates More Fear and a Vicious Sell-Off
Global Debt Crisis Weighs In-Everything is Interconnected Panic selling has eased after European market closes but we are still down 3%. 10 Year treasuries are under 2.5%.Banks cannot handle the...
Wild Turnaround Day- RoboTraders Again?
Time to Follow the Technicals If you missed the morning action today you were better off unless you were bargain hunting. It looked like another ugly free-fall day at about 10 am EDT until some...
Sell Off in the Eighth Day but Look to AMGN and GPRO for Help
Classic Risk-Off Market With 10 Year Yield at 2.6%-Healthcare Sector Still Selling Off Down 1.68% The market is not celebrating the Debt-Limit Deal. A new reality may be setting now that all the...
Debt Deal: Healthcare Stocks Sell Off On Potential Medicare Cuts
Triggers: Debt Ceiling and Skilled Nursing Stocks There is a broad sell-off in healthcare stocks today on fears that the debt ceiling deal would cut healthcare spending.A few weeks ago a few hedgies...
Data Shows How Dx Companies Are Growing Through M&A
Here is 2011 Deal Data from IVDnews.com one of the leading data and news sites covering Diagnostics. Contact IVD News for details on all IVD deals for 2011. Recent M&A examples from our focus...
Rayno Life Science Tools and Diagnostics: What’s Hot and Not?
It was a tough week in Life Science Tools and Diagnostics with many crosscurrents: debt ceiling uncertainty, earnings shortfalls, lackluster economic data and European debt crisis. The usual...
Nice Snapback Rally in Life Science Today-ILMN Up 3.93%, Abaxis (ABAX) Leads Up 5%
Rayno Life Science Portfolio Recovers Up 1.73%; Jobless Claims Help The thrashing of Illumina (ILMN) yesterday appears to be overdone as the stock is recovering to the $60 area on volume of over...
Illumina Guidance Drags Down Life Science Tools Sector: Maintain Caution
Dog Days of Summer Lie Ahead- Q3 Seasonality in Life Sciences is Weak A vicious 16% sell-off in Illumina Inc. (ILMN $58.43) due to revised 2011 guidance and subsequent analysts' reduced outlook....
